Key Takeaways TECH struck a deal with USP to distribute mAb and AAV standards, alongside its Maurice analytics platform. TECH aims to ease analytical challenges in mAb and gene therapy development through this partnership. TECH's tools enable efficient, integrated analysis of complex biologics from development to product release.Bio-Techne Corp. (TECH) has recently entered into a distribution agreement with the U.S. Pharmacopeia (“USP”) to sell USP monoclonal antibody (mAb) and recombinant adeno-associate ...

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Melanie Solomon - IR Ming Hsieh - Chairman and CEO Brandon Perthuis - Chief Commercial Officer Paul Kim - CFO Conference Call Participants David Westenberg - Piper Sandler Lu Li - UBS Andrew Cooper - Raymond James Operator Greetings, and welcome to the Fulgent Genetics, Inc. Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question and answer ...